GoHealth, Inc.
GOCONASDAQFinancial Services● Active
$0.38
$-0.29(-43.62%)
Market Cap$11134947
P/E Ratio—
52W High$7.116
52W Low$0.341
GoHealth, Inc. (GOCO) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
GOCO · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 18, 2026EPS Actual
-$2.36
Est. -$2.40 · +1.7%
Revenue
$0.02B
Est. $0.02B · +8.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 18, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 4-Quarter EPS Beat Streak
GOCO reports quarterly as a NASDAQ-listed Insurance - Brokers company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | -$2.16 | — | — | — | $0.02B | — |
| ▲ Q2 FY2026 | May 18, 2026 | -$2.40 | -$2.36 | +1.7% | $0.02B | $0.02B | +8.0% |
| ▲ Q1 FY2026 | Mar 31, 2026 | -$2.69 | -$1.03 | +61.7% | $0.01B | $0.09B | -85.7% |
| ▲ Q4 FY2025 | Nov 13, 2025 | -$2.06 | -$0.19 | +90.8% | $0.03B | $0.09B | -61.4% |
| ▲ Q3 FY2025 | Aug 7, 2025 | -$2.60 | -$1.23 | +52.7% | $0.09B | $0.12B | -18.4% |
| ▼ Q2 FY2025 | May 13, 2025 | -$0.26 | -$0.47 | -80.8% | $0.22B | $0.23B | -2.2% |
| ▲ Q1 FY2025 | Feb 27, 2025 | $1.16 | $2.41 | +107.8% | $0.39B | $0.19B | +104.0% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -$3.19 | -$3.73 | -16.9% | $0.12B | $0.33B | -63.8% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
-$2.16
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 18, 2026Beat
EPS Actual
-$2.36
EPS Est.
-$2.40
EPS Surpr.
+1.7%
Revenue
$0.02B
Q1 FY2026
Mar 31, 2026Beat
EPS Actual
-$1.03
EPS Est.
-$2.69
EPS Surpr.
+61.7%
Revenue
$0.01B
Q4 FY2025
Nov 13, 2025Beat
EPS Actual
-$0.19
EPS Est.
-$2.06
EPS Surpr.
+90.8%
Revenue
$0.03B
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
-$1.23
EPS Est.
-$2.60
EPS Surpr.
+52.7%
Revenue
$0.09B
Q2 FY2025
May 13, 2025Miss
EPS Actual
-$0.47
EPS Est.
-$0.26
EPS Surpr.
-80.8%
Revenue
$0.22B
Q1 FY2025
Feb 27, 2025Beat
EPS Actual
$2.41
EPS Est.
$1.16
EPS Surpr.
+107.8%
Revenue
$0.39B
Q4 FY2024
Nov 7, 2024Miss
EPS Actual
-$3.73
EPS Est.
-$3.19
EPS Surpr.
-16.9%
Revenue
$0.12B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.25 | $0.52 | $0.74 | 1 |
| Q3 FY2027 | $-3.97 | $-2.78 | $-1.32 | 1 |
| Q2 FY2027 | $-3.65 | $-2.56 | $-1.22 | 1 |
| Q1 FY2027 | $-2.38 | $-1.67 | $-0.79 | 1 |
| Q4 FY2026 | $-1.23 | $-0.86 | $-0.41 | 1 |
| Q3 FY2026 | $-2.84 | $-2.10 | $-1.71 | 3 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.1B | $0.2B | $0.3B | 1 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2027 | $0.0B | $0.1B | $0.1B | 1 |
| Q1 FY2027 | $0.0B | $0.1B | $0.1B | 1 |
| Q4 FY2026 | $0.1B | $0.1B | $0.2B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 18, 2026 | +1.7% | $0.85 | $0.86 | +0.87% |
| ▲ Q1 FY2026 | Mar 31, 2026 | +61.7% | $1.53 | $1.51 | -1.31% |
| ▲ Q4 FY2025 | Nov 13, 2025 | +90.8% | $3.44 | $2.61 | -24.13% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +52.7% | $6.31 | $5.73 | -9.19% |
| ▼ Q2 FY2025 | May 13, 2025 | -80.8% | $8.13 | $8.11 | -0.25% |
| ▲ Q1 FY2025 | Feb 27, 2025 | +107.8% | $18.41 | $15.75 | -14.45% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -16.9% | $12.75 | $11.78 | -7.61% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +69.6% | $11.55 | $9.15 | -20.78% |
Q2 FY2026+0.87%
Report Date
May 18, 2026
EPS Beat/Miss
+1.7%
Price Before
$0.85
Price After
$0.86
Q1 FY2026-1.31%
Report Date
Mar 31, 2026
EPS Beat/Miss
+61.7%
Price Before
$1.53
Price After
$1.51
Q4 FY2025-24.13%
Report Date
Nov 13, 2025
EPS Beat/Miss
+90.8%
Price Before
$3.44
Price After
$2.61
Q3 FY2025-9.19%
Report Date
Aug 7, 2025
EPS Beat/Miss
+52.7%
Price Before
$6.31
Price After
$5.73
Q2 FY2025-0.25%
Report Date
May 13, 2025
EPS Beat/Miss
-80.8%
Price Before
$8.13
Price After
$8.11
Q1 FY2025-14.45%
Report Date
Feb 27, 2025
EPS Beat/Miss
+107.8%
Price Before
$18.41
Price After
$15.75
Q4 FY2024-7.61%
Report Date
Nov 7, 2024
EPS Beat/Miss
-16.9%
Price Before
$12.75
Price After
$11.78
Q3 FY2024-20.78%
Report Date
Aug 8, 2024
EPS Beat/Miss
+69.6%
Price Before
$11.55
Price After
$9.15
Avg Beat Reaction-11.50%
Avg Miss Reaction-3.93%
Beat Rate6 / 8 quarters
Largest Move-24.13% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: GOCO ends December
GoHealth, Inc. (GOCO) most recently reported earnings on May 18, 2026 for Q2 FY2026, posting EPS of $-2.36 — beating the analyst consensus of $-2.40 by +1.7%. GOCO has beaten EPS estimates for 4 consecutive quarters. The next GOCO earnings date is expected around September 1, 2026.
Each quarter, investors track GOCO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GOCO revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GOCO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
GOCO earnings · 5 questionsGoHealth, Inc.'s next earnings report is expected around September 1, 2026. GOCO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GOCO historically reports after market close (AMC).
GOCO earnings datewhen is GOCO earningsGOCO next earnings datewhen does GOCO report earningsGOCO earnings calendar
▸ Source: FMP · GoHealth, Inc. SEC filings · US GAAP · GoHealth, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026